RUCDR Infinite Biologics
145 Bevier Road
7 articles with RUCDR Infinite Biologics
Company spins off from Rutgers University to strengthen its impact and leadership position as a Next-Generation Central Laboratory
The new at-home saliva self-collection assay allows for broader screening than the standard and uncomfortable method using nose and throat swabs at a healthcare facility or testing location that requires a physical interaction with a healthcare professional.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 8, 2020.
The U.S. Food and Drug Administration granted emergency use authorization to Rutgers’ RUCDR Infinite Biologics for its test that uses saliva.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 13, 2020.
PreAnalytiX, NuGEN Technologies, Inc. And RUCDR Infinite Biologics Partner To Develop Clinically Validated RNA-Seq Workflow For Whole Blood Samples
RUCDR Infinite Biologics Release: BioProcessing Solutions Alliance Wins Million Veteran Program Genotyping Contract